Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

All three major indices are trading down today with the

Dow Jones Industrial Average

(

^DJI

) trading down 47.51 points (-0.3%) at 17,551 as of Tuesday, Aug. 4, 2015, 4:20 PM ET. The NYSE advances/declines ratio sits at 1,368 issues advancing vs. 1,676 declining with 154 unchanged.

The Chemicals industry as a whole closed the day down 0.1% versus the S&P 500, which was down 0.2%. Top gainers within the Chemicals industry included

Methes Energies International

(

MEIL

), up 2.1%,

Gulf Resources

(

GURE

), up 4.6%,

BioAmber

(

BIOA

), up 3.8%,

Amyris

(

AMRS

), up 7.0% and

Omnova Solutions

(

OMN

), up 2.3%.

TheStreet Ratings Group would like to highlight 3 stocks pushing the industry higher today:

Amyris

(

AMRS

) is one of the companies that pushed the Chemicals industry higher today. Amyris was up $0.11 (7.0%) to $1.67 on light volume. Throughout the day, 110,289 shares of Amyris exchanged hands as compared to its average daily volume of 345,600 shares. The stock ranged in a price between $1.62-$1.74 after having opened the day at $1.62 as compared to the previous trading day's close of $1.56.

Amyris, Inc. provides various alternatives to a range of petroleum-sourced products for the consumer care, specialty chemical, and transportation fuel markets worldwide. Amyris has a market cap of $130.3 million and is part of the basic materials sector. Shares are down 24.3% year-to-date as of the close of trading on Monday. Currently there are no analysts who rate Amyris a buy, no analysts rate it a sell, and 2 rate it a hold.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreet Ratings rates Amyris as a

sell

. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, poor profit margins and generally disappointing historical performance in the stock itself.

Highlights from TheStreet Ratings analysis on AMRS go as follows:

  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Oil, Gas & Consumable Fuels industry. The net income has significantly decreased by 418.8% when compared to the same quarter one year ago, falling from $16.39 million to -$52.24 million.
  • The gross profit margin for AMYRIS INC is currently lower than what is desirable, coming in at 31.25%. Despite the low profit margin, it has increased significantly from the same period last year. Despite the mixed results of the gross profit margin, AMRS's net profit margin of -663.61% significantly underperformed when compared to the industry average.
  • Despite any intermediate fluctuations, we have only bad news to report on this stock's performance over the last year: it has tumbled by 56.89%, worse than the S&P 500's performance. Consistent with the plunge in the stock price, the company's earnings per share are down 94.11% compared to the year-earlier quarter. Naturally, the overall market trend is bound to be a significant factor. However, in one sense, the stock's sharp decline last year is a positive for future investors, making it cheaper (in proportion to its earnings over the past year) than most other stocks in its industry. But due to other concerns, we feel the stock is still not a good buy right now.
  • AMYRIS INC has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, AMYRIS INC continued to lose money by earning -$1.46 versus -$3.10 in the prior year. This year, the market expects an improvement in earnings (-$1.00 versus -$1.46).
  • Net operating cash flow has significantly increased by 67.08% to -$3.28 million when compared to the same quarter last year. In addition, AMYRIS INC has also vastly surpassed the industry average cash flow growth rate of -48.80%.

You can view the full analysis from the report here:

Amyris Ratings Report

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

At the close,

BioAmber

(

BIOA

) was up $0.27 (3.8%) to $7.32 on average volume. Throughout the day, 73,624 shares of BioAmber exchanged hands as compared to its average daily volume of 61,200 shares. The stock ranged in a price between $7.05-$7.59 after having opened the day at $7.05 as compared to the previous trading day's close of $7.05.

BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various chemical market customers in the United States. BioAmber has a market cap of $180.9 million and is part of the basic materials sector. Shares are down 16.0% year-to-date as of the close of trading on Monday. Currently there are 2 analysts who rate BioAmber a buy, no analysts rate it a sell, and none rate it a hold.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreet Ratings rates BioAmber as a

sell

. The company's weaknesses can be seen in multiple areas, such as its poor profit margins, weak operating cash flow and generally disappointing historical performance in the stock itself.

Highlights from TheStreet Ratings analysis on BIOA go as follows:

  • The gross profit margin for BIOAMBER INC is rather low; currently it is at 15.53%. It has decreased from the same quarter the previous year. Along with this, the net profit margin of -2250.13% is significantly below that of the industry average.
  • Net operating cash flow has decreased to -$5.92 million or 21.69% when compared to the same quarter last year. In conjunction, when comparing current results to the industry average, BIOAMBER INC has marginally lower results.
  • BIOA's stock share price has done very poorly compared to where it was a year ago: Despite any rallies, the net result is that it is down by 40.99%, which is also worse that the performance of the S&P 500 Index. Investors have so far failed to pay much attention to the earnings improvements the company has managed to achieve over the last quarter. Naturally, the overall market trend is bound to be a significant factor. However, in one sense, the stock's sharp decline last year is a positive for future investors, making it cheaper (in proportion to its earnings over the past year) than most other stocks in its industry. But due to other concerns, we feel the stock is still not a good buy right now.
  • The company's current return on equity greatly increased when compared to its ROE from the same quarter one year prior. This is a signal of significant strength within the corporation. Compared to other companies in the Chemicals industry and the overall market, BIOAMBER INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • BIOAMBER INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, BIOAMBER INC reported poor results of -$2.41 versus -$1.80 in the prior year. This year, the market expects an improvement in earnings (-$1.64 versus -$2.41).

You can view the full analysis from the report here:

BioAmber Ratings Report

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Gulf Resources

(

GURE

) was another company that pushed the Chemicals industry higher today. Gulf Resources was up $0.09 (4.6%) to $2.04 on light volume. Throughout the day, 53,028 shares of Gulf Resources exchanged hands as compared to its average daily volume of 124,400 shares. The stock ranged in a price between $1.94-$2.05 after having opened the day at $1.95 as compared to the previous trading day's close of $1.95.

Gulf Resources, Inc., through its subsidiaries, manufactures and trades in bromine, crude salt, and specialty chemical products in the People's Republic of China. It operates in three segments: Bromine, Crude Salt, and Chemical Products. Gulf Resources has a market cap of $88.7 million and is part of the basic materials sector. Shares are up 68.1% year-to-date as of the close of trading on Monday. Currently there are no analysts who rate Gulf Resources a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates

Gulf Resources

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, increase in net income and good cash flow from operations. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity.

Highlights from TheStreet Ratings analysis on GURE go as follows:

  • The revenue growth greatly exceeded the industry average of 11.5%. Since the same quarter one year prior, revenues rose by 36.2%. This growth in revenue appears to have trickled down to the company's bottom line, improving the earnings per share.
  • GURE's debt-to-equity ratio is very low at 0.01 and is currently below that of the industry average, implying that there has been very successful management of debt levels. Along with this, the company maintains a quick ratio of 7.85, which clearly demonstrates the ability to cover short-term cash needs.
  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Chemicals industry. The net income increased by 24.0% when compared to the same quarter one year prior, going from $4.29 million to $5.32 million.
  • Net operating cash flow has increased to $17.78 million or 38.68% when compared to the same quarter last year. In addition, GULF RESOURCES INC has also vastly surpassed the industry average cash flow growth rate of -16.51%.

You can view the full analysis from the report here:

Gulf Resources Ratings Report

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.